Klaus Bendtzen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Larsen Signe; Bendtzen Klaus; Nielsen Ole Haagen
[Extraintestinal manifestations in inflammatory bowel disease]
Hedegaard Chris J; Chen Ning; Sellebjerg Finn; Sørensen Per Soelberg; Leslie R Graham Q; Bendtzen Klaus; Nielsen Claus H
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP.
Enevold Christian; Oturai Annette Bang; Sørensen Per Soelberg; Ryder Lars Peter; Koch-Henriksen Nils; Bendtzen Klaus
Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Klaus Bendtzen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Larsen Signe; Bendtzen Klaus; Nielsen Ole Haagen
[Extraintestinal manifestations in inflammatory bowel disease]
Ugeskrift for laeger 2009;171(43):3078-83.
2009: Hedegaard Chris J; Chen Ning; Sellebjerg Finn; Sørensen Per Soelberg; Leslie R Graham Q; Bendtzen Klaus; Nielsen Claus H
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP.
Immunology 2009;128(1 Suppl):e451-61.
2009: Enevold Christian; Oturai Annette Bang; Sørensen Per Soelberg; Ryder Lars Peter; Koch-Henriksen Nils; Bendtzen Klaus
Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.
Journal of neuroimmunology 2009;212(1-2):125-31.
2009: Borch Tanja Skuldbøl; Løbner Morten; Bendtzen Klaus; Holmstrup Palle; Nielsen Claus Henrik
Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis.
Journal of periodontology 2009;80(5):800-7.
2009: Sørensen Lars K; Havemose-Poulsen Anne; Bendtzen Klaus; Holmstrup Palle
Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
Journal of periodontology 2009;80(2):282-9.
2008: Geismar Karen; Enevold Christian; Sørensen Lars Korsbaek; Gyntelberg Finn; Bendtzen Klaus; Sigurd Bjarne; Holmstrup Palle
Involvement of interleukin-1 genotypes in the association of coronary heart disease with periodontitis.
Journal of periodontology 2008;79(12):2322-30.
2008: Mangano K; Sardesai N Y; Quattrocchi C; Mazzon E; Cuzzocrea S; Bendtzen K; Meroni P L; Kim J J; Nicoletti F
Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats.
British journal of pharmacology 2008;155(5):722-30.
2008: Hedegaard Chris J; Krakauer Martin; Bendtzen Klaus; Sørensen Per Soelberg; Sellebjerg Finn; Nielsen Claus H
The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2008;129(1):80-9.
2008: Hedegaard Chris J; Krakauer Martin; Bendtzen Klaus; Lund Henrik; Sellebjerg Finn; Nielsen Claus H
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.
Immunology 2008;125(2):161-9.
2008: Sorensen P S; Koch-Henriksen N; Flachs E M; Bendtzen K
Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):837-42.
2008: Løbner Morten; Walsted Anette; Larsen Rune; Bendtzen Klaus; Nielsen Claus Henrik
Enhancement of human adaptive immune responses by administration of a high-molecular-weight polysaccharide extract from the cyanobacterium Arthrospira platensis.
Journal of medicinal food 2008;11(2):313-22.
2008: Skov Lone; Hegedüs Laszlo; Madsbad Sten; Bendtzen Klaus
[New biological drugs for the treatment of chronic inflammatory diseases]
Ugeskrift for laeger 2008;170(24):2162.
2008: Baslund Bo; Bendtzen Klaus
[Biopharmaceuticals in the treatment of rheumatoid arthritis]
Ugeskrift for laeger 2008;170(24):2108-10.
2008: Skov Lone; Bendtzen Klaus
[Biological response modifiers in the treatment of immunoinflammatory diseases]
Ugeskrift for laeger 2008;170(24):2120-6.
2008: Bendtzen Klaus
[The immune system and inflammatory diseases]
Ugeskrift for laeger 2008;170(24):2110-5.
2008: Nielsen Ole Haagen; Bendtzen Klaus
[Biological drugs in the treatment of immunoinflammatory diseases]
Ugeskrift for laeger 2008;170(24):2103.
2008: Mangano Katia; Dati Gabriele; Quattrocchi Cinzia; Proietti Lidia; Mazzarino Clorinda; Di Marco Roberto; Bendtzen Klaus; Greco Beatrice; Zaratin Paola; Nicoletti Ferdinando
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barrè syndrome.
Journal of neuroimmunology 2008;196(1-2):107-15.
2008: Mangano Katia; Sardesai Niranjan; D'Alcamo Maria; Libra Massimo; Malaguarnera Lucia; Donia Marco; Bendtzen Klaus; Meroni Pierluigi; Nicoletti Ferdinando
In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027.
European journal of pharmacology 2008;586(1-3):313-21.
2008: Ainsworth Mark A; Bendtzen Klaus; Brynskov Jørn
Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease.
The American journal of gastroenterology 2008;103(4):944-8.
2008: Sørensen Lars K; Havemose-Poulsen Anne; Sønder Søren U; Bendtzen Klaus; Holmstrup Palle
Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis.
Journal of periodontology 2008;79(3):477-85.
2008: Farrell Rachel; Bendtzen Klaus; Bertolotto Antonio; Clark Berwyn; Comabella Manuel; Deisenhammer Florian; Fogdell-Hahn Anna; Giovannoni Gavin; Hartung Hans Peter; Hemmer Bernard; Hillert Jan; Kappos Ludwig; Killestein Joep; Lindberg Raija; Montalban Xavier; Polman Chris; Sorensen Per Soelberg;
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
The Journal of international medical research 2008;36(1):204-8; author reply 208-10.
2007: Svenson M; Geborek P; Saxne T; Bendtzen K
Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.
Rheumatology (Oxford, England) 2007;46(12):1828-34.
2007: Galle Pia; Jensen Lene; Andersson Christina; Cuzzocrea Salvatore; Di Paola Rosanna; Nicoletti Ferdinando; Svenson Morten; Bendtzen Klaus; Thomsen Allan R; Hansen Morten B
Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation.
International immunopharmacology 2007;7(13):1704-13.
2007: Nielsen Claus H; El Fassi Daniel; Hasselbalch Hans C; Bendtzen Klaus; Hegedüs Laszlo
B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.
Expert opinion on biological therapy 2007;7(7):1061-78.
2007: Sorensen P S; Koch-Henriksen N; Bendtzen K
Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(5):616-21.
2007: Bendtzen Klaus; Svenson Morten; Hansen Morten B
GM-CSF autoantibodies in pulmonary alveolar proteinosis.
The New England journal of medicine 2007;356(19):2001; author reply 2002.
2007: Bovin Lone Frier; Brynskov Jørn; Hegedüs Laszlo; Jess Tine; Nielsen Claus Henrik; Bendtzen Klaus
Gene expression profiling in autoimmune diseases: chronic inflammation or disease specific patterns?
Autoimmunity 2007;40(3):191-201.
2007: Nielsen C H; Albertsen L; Bendtzen K; Baslund B
Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells.
Clinical and experimental immunology 2007;148(2):288-95.
2007: Havemose-Poulsen Anne; Sørensen Lars Korsbaek; Bendtzen Klaus; Holmstrup Palle
Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.
Journal of periodontology 2007;78(3):475-92.
2007: Nielsen C H; Hegedüs L; Rieneck K; Moeller A C; Leslie R G Q; Bendtzen K
Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.
Clinical and experimental immunology 2007;147(2):287-95.
2007: Bendtzen Klaus; Geborek Pierre; Svenson Morten; Larsson Lotta; Kapetanovic Meliha C; Saxne Tore
[Treatment of rheumatoid arthritis (RA) with anti-TNF-alpha antibody (Remicade). Individual monitoring of bioavailability and immunogenicity--secondary publication]
Ugeskrift for laeger 2007;169(5):420-3.
2006: Bendtzen Klaus; Geborek Pierre; Svenson Morten; Larsson Lotta; Kapetanovic Meliha C; Saxne Tore
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Arthritis and rheumatism 2006;54(12):3782-9.
2006: Sønder Søren Ulrik Salling; Woetmann Anders; Odum Niels; Bendtzen Klaus
Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor.
Apoptosis : an international journal on programmed cell death 2006;11(12):2159-65.
2006: El Fassi Daniel; Nielsen Claus Henrik; Bendtzen Klaus
[Rituximab (MabThera) as treatment of active rheumatoid arthritis]
Ugeskrift for laeger 2006;168(47):4079-81.
2006: Sorensen P Soelberg; Tscherning T; Mathiesen H K; Langkilde A R; Ross C; Ravnborg M; Bendtzen K
Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS.
Neurology 2006;67(9):1681-3.
2006: Forner Lone; Nielsen Claus Henrik; Bendtzen Klaus; Larsen Tove; Holmstrup Palle
Increased plasma levels of IL-6 in bacteremic periodontis patients after scaling.
Journal of clinical periodontology 2006;33(10):724-9.
2006: Petersen Bodil; Bendtzen Klaus; Koch-Henriksen Nils; Ravnborg Mads; Ross Christian; Sorensen Per Soelberg;
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(3):247-52.
2006: Sønder Søren Ulrik Salling; Mikkelsen Marianne; Rieneck Klaus; Hedegaard Chris Juul; Bendtzen Klaus
Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction.
British journal of pharmacology 2006;148(1):46-53.
2006: Mikkelsen M; Sønder S U; Nersting J; Bendtzen K
Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression.
Apoptosis : an international journal on programmed cell death 2006;11(4):573-9.
2006: Nielsen Claus H; Moeller Ane Christine; Hegedüs Laszlo; Bendtzen Klaus; Leslie R Graham Q
Self-reactive CD4+ T cells and B cells in the blood in health and autoimmune disease: increased frequency of thyroglobulin-reactive cells in Graves' disease.
Journal of clinical immunology 2006;26(2):126-37.
2006: Havemose-Poulsen Anne; Westergaard Jytte; Stoltze Kaj; Skjødt Henrik; Danneskiold-Samsøe Bente; Locht Henning; Bendtzen Klaus; Holmstrup Palle
Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.
Journal of periodontology 2006;77(2):280-8.
2006: Ross C; Clemmesen K M; Sørensen P S; Koch-Henriksen N; Bendtzen K
Measuring and evaluating interferon beta-induced antibodies in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(1):39-46.
2005: Havemose-Poulsen Anne; Sørensen Lars Korsbaek; Stoltze Kaj; Bendtzen Klaus; Holmstrup Palle
Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis.
Journal of periodontology 2005;76(12):2276-85.
2005: Sorensen P Soelberg; Koch-Henriksen N; Ross C; Clemmesen K M; Bendtzen K;
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy.
Neurology 2005;65(1):33-9.
2005: Grauballe M C B; Bentzen B H; Björnsson M; Moe D; Jonassen T E N; Bendtzen K; Stoltze K; Holmstrup P
The effect of spironolactone on experimental periodontitis in rats.
Journal of periodontal research 2005;40(3):212-7.
2005: Bjørnhart Birgitte; Svenningsen Pernille; Gudbrandsdottir Sif; Zak Marek; Nielsen Susan; Bendtzen Klaus; Müller Klaus
Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.
International immunopharmacology 2005;5(1):73-7.
2005: Andersen Johnny; Heilmann Carsten; Jacobsen Niels; Bendtzen Klaus; Müller Klaus
Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation.
International immunopharmacology 2005;5(1):67-71.
2004: Galle Pia; Svenson Morten; Bendtzen Klaus; Hansen Morten B
High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors.
European journal of immunology 2004;34(11):3267-75.
2004: Sørensen Soelberg; Koch-Henriksen Nils J; Pedersen Christian Ross; Clemmesen Katja Maria; Bendtzen Klaus; Frederiksen Jette Lautrup; Jensen Kai; Kristensen Ole; Petersen Thor; Rasmussen Søren; Ravnborg Mads; Stenager Egon;
[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis]
Ugeskrift for laeger 2004;166(41):3606-9.
2004: Di Paola Rosanna; Di Marco Roberto; Mazzon Emanuela; Genovese Tiziana; Bendtzen Klaus; Macrì Battesimo; Nicoletti Ferdinando; Cuzzocrea Salvatore
Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody.
Clinical immunology (Orlando, Fla.) 2004;113(1):64-73.
2004: Bendtzen Klaus; Hansen Peter Riis; Rieneck Klaus;
[Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis]
Ugeskrift for laeger 2004;166(37):3203-7.
2004: Bendtzen Klaus
[Adalimumab in the treatment of rheumatoid arthritis]
Ugeskrift for laeger 2004;166(26-31):2552-4.
2004: Bovin Lone Frier; Rieneck Klaus; Workman Christopher; Nielsen Henrik; Sørensen Søren Freiesleben; Skjødt Henrik; Florescu Adrian; Brunak Søren; Bendtzen Klaus
Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor.
Immunology letters 2004;93(2-3):217-26.
2004: Bendtzen Klaus
Natural and therapy-induced antibodies to cytokines.
Drug discovery today 2004;9(6):259.
2004: Hansen Peter Riis; Rieneck Klaus; Bendtzen Klaus
Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells.
Immunology letters 2004;91(2-3):87-91.
2004: Gudbrandsdottir S; Larsen R; Sørensen L K; Nielsen S; Hansen M B; Svenson M; Bendtzen K; Müller K
TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis.
Clinical and experimental rheumatology 2004;22(1):118-24.
2004: Galle Pia; Hougs Lotte; Barington Torben; Svenson Morten; Svejgaard Arne; Thomsen Allan R; Bendtzen Klaus; Hansen Morten B
Knocking out IL-6 by vaccination.
European journal of immunology 2004;34(1):291-300.
2004: Gudbrandsdottir S; Bliddal H; Petri A; Terslev L; Danneskiold-Samsoe B; Bjørnhart B; Bendtzen K; Müller K
Plasma TNF binding capacity profiles during treatment with etanercept in rheumatoid arthritis.
Scandinavian journal of rheumatology 2004;33(6):385-8.
2004: Christensen Hanne; Johannesen Helle Hjorth; Christensen Anders Fogh; Bendtzen Klaus; Boysen Gudrun
Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha.
Cerebrovascular diseases (Basel, Switzerland) 2004;18(3):194-9.
2003: Di Marco Roberto; Mangano Katia; Quattrocchi Cinzia; Musumeci Rosario; Speciale Anna Maria; Papaccio Gianpaolo; Buschard Karsten; Bendtzen Klaus; Nicoletti Ferdinando
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats.
Clinical immunology (Orlando, Fla.) 2003;109(3):266-71.
2003: Bendtzen Klaus
[Immunogenicity of biopharmaceuticals. Experiences with beta-interferon, EPO and anti-TNF]
Ugeskrift for laeger 2003;165(48):4629-32.
2003: Bendtzen Klaus
[Problems with clinical use of recombinant proteins]
Ugeskrift for laeger 2003;165(48):4625.
2003: Sorensen Per Soelberg; Ross Christian; Clemmesen Katja Maria; Bendtzen Klaus; Frederiksen Jette Lautrup; Jensen Kai; Kristensen Ole; Petersen Thor; Rasmussen Soren; Ravnborg Mads; Stenager Egon; Koch-Henriksen Nils;
Antibodies to IFN-beta: the Danish National IFN-beta Project.
Neurology 2003;61(9 Suppl 5):S27-8.
2003: Bendtzen Klaus
Anti-IFN BAb and NAb antibodies: a minireview.
Neurology 2003;61(9 Suppl 5):S6-10.
2003: Sorensen Per Soelberg; Ross Christian; Clemmesen Katja Maria; Bendtzen Klaus; Frederiksen Jette Lautrup; Jensen Kai; Kristensen Ole; Petersen Thor; Rasmussen Soren; Ravnborg Mads; Stenager Egon; Koch-Henriksen Nils;
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis.
Lancet 2003;362(9391):1184-91.
2003: Bendtzen K; Hansen P R; Rieneck K;
Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis.
Clinical and experimental immunology 2003;134(1):151-8.
2003: Nersting Jacob; Svenson Morten; Andersen Vagn; Bendtzen Klaus
Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha.
Immunology letters 2003;89(1):59-65.
2003: Nicoletti Ferdinando; Di Marco Roberto; Papaccio Gianpaolo; Conget Ignacio; Gomis Ramon; Bernardini Renato; Sims John E; Shoenfeld Yehuda; Bendtzen Klaus
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
European journal of immunology 2003;33(8):2278-86.
2003: Birkeland S A; Hamilton-Dutoit S; Bendtzen K
Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation.
Transplantation 2003;76(1):153-8.
2003: Kaneko Tetsushi; Itoh Masahiro; Nakamura Yoichi; Iimura Akira; Hayashi Shogo; Takahashi Kodo; Stivala Franca; Bendtzen Klaus; Nicoletti Ferdinando
Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis.
Cytokine 2003;22(1-2):50-3.
2003: Svenson Morten; Jacobi Henrik H; Bødtger Uffe; Poulsen Lars K; Rieneck Klaus; Bendtzen Klaus
Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.
Molecular immunology 2003;39(10):603-12.
2002: Petersen Søren Lykke; Russell Charlotte Astrid; Bendtzen Klaus; Vindeløv Lars Lindhardt
Optimisation of the CT h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture.
Immunology letters 2002;84(1):29-39.
2002: Papaccio Gianpaolo; Nicoletti Ferdinando; Pisanti Francesco A; Galdieri Michela; Bendtzen Klaus
An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells.
Molecular medicine (Cambridge, Mass.) 2002;8(9):536-45.
2002: Nersting Jacob; Andersen Vagn; Bendtzen Klaus
[Autoinflammatory disease: a new concept]
Ugeskrift for laeger 2002;164(37):4269-71.
2002: Christensen Hanne; Boysen Gudrun; Johannesen Helle Hjorth; Christensen Erik; Bendtzen Klaus
Deteriorating ischaemic stroke. cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke.
Journal of the neurological sciences 2002;201(1-2):1-7.
2002: Nicoletti F; Conget I; Di Mauro M; Di Marco R; Mazzarino M C; Bendtzen K; Messina A; Gomis R
Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease.
Diabetologia 2002;45(8):1107-10.
2002: Graudal N A; Svenson M; Tarp U; Garred P; Jurik A-G; Bendtzen K
Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome.
Annals of the rheumatic diseases 2002;61(7):598-602.
2002: Ross Christian; Engler Claus Bødker; Sander Birgit; Bendtzen Klaus
IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(4):421-6.
2002: Christensen Hanne; Boysen Gudrun; Christensen Erik; Johannesen Helle Hjorth; Bendtzen Klaus
Plasma cytokines in acute stroke.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2002;11(2):72-9.
2002: Li Lu; Itoh Masahiro; Ablake Maila; Macrì Battesimo; Bendtzen Klaus; Nicoletti Ferdinando
Prevention of murine experimental autoimmune orchitis by recombinant human interleukin-6.
Clinical immunology (Orlando, Fla.) 2002;102(2):135-7.
2001: Jónasdóttir O; Petersen J; Bendtzen K
Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2001;109(11):781-6.
2001: Bendtzen K; Bovin L F; Andersen V; Rieneck K; Svenson M
[Toll-like receptors. What can we learn about the immune system from banana flies and a mouse strain]
Ugeskrift for laeger 2001;163(34):4562-5.
2001: Nicoletti F; Di Marco R; Mangano K; Patti F; Reggio E; Nicoletti A; Bendtzen K; Reggio A
Increased serum levels of interleukin-18 in patients with multiple sclerosis.
Neurology 2001;57(2):342-4.
2001: Nicoletti F; Di Marco R; Sacerdote P; Meroni P; Mangano K; Edwards C; Bartorelli A; Bendtzen K; Panerai A
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14.
Antimicrobial agents and chemotherapy 2001;45(5):1591-4.
2001: Di Marco R; Puglisi G; Papaccio G; Nicoletti A; Patti F; Reggio A; Bendtzen K; Nicoletti F
Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(2):101-4.
2001: Nicoletti F; Conget I; Di Marco R; Speciale A M; Morìnigo R; Bendtzen K; Gomis R
Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes.
Diabetologia 2001;44(3):309-11.
2000: Rieneck K; Bovin L F; Josefsen K; Buschard K; Svenson M; Bendtzen K
Massive parallel gene expression profiling of RINm5F pancreatic islet beta-cells stimulated with interleukin-1beta.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2000;108(12):855-72.
2000: Pedersen G; Saermark T; Bendtzen K; Brynskov J
Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion.
Autoimmunity 2000;32(4):255-63.
2000: Nicoletti F; Di Marco R; Conget I; Gomis R; Edwards C; Papaccio G; Bendtzen K; Sandler S
Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin.
Journal of autoimmunity 2000;15(4):395-405.
2000: Ross C; Clemmesen K M; Svenson M; Sørensen P S; Koch-Henriksen N; Skovgaard G L; Bendtzen K
Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group.
Annals of neurology 2000;48(5):706-12.
2000: Nicoletti F; Di Marco R; Zaccone P; Salvaggio A; Magro G; Bendtzen K; Meroni P
Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):728-33.
2000: Pedersen G; Saermark T; Horn T; Giese B; Bendtzen K; Brynskov J
Cytokine-induced impairment of short-chain fatty acid oxidation and viability in human colonic epithelial cells.
Cytokine 2000;12(9):1400-4.
2000: Papaccio G; Nicoletti F; Pisanti F A; Bendtzen K; Galdieri M
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells.
Endocrinology 2000;141(4):1500-5.
2000: Bendtzen K; Hansen M B; Ross C; Svenson M
Detection of autoantibodies to cytokines.
Molecular biotechnology 2000;14(3):251-61.
2000: Svenson M; Hansen M B; Thomsen A R; Diamant M; Nansen A; Rieneck K; Otterness I G; Bendtzen K
Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha.
Journal of immunological methods 2000;236(1-2):1-8.
2000: Meyer C N; Svenson M; Schade Larsen C; Odum N; Skinhøj P; Bendtzen K
Low prevalence of antibodies and other plasma factors binding to CC chemokines and IL-2 in HIV-positive patients.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2000;108(2):122-30.
2000: Andersen L S; Petersen J; Bendtzen K
Production of interleukin (IL)-1beta, IL-1 receptor antagonist and IL-10 by blood mononuclear cells in chronic arthritis.
Cytokine 2000;12(1):62-8.
1999: Nielsen H; Petersen A A; Skjødt H; Hørslev-Petersen K; Bendtzen K
Blood levels of CD11b+ memory T lymphocytes are selectively upregulated in patients with active rheumatoid arthritis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1999;107(12):1124-30.
1999: Nicoletti F; Zaccone P; Conget I; Gomis R; Möller C; Meroni P L; Bendtzen K; Trepicchio W; Sandler S
Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice.
Diabetes 1999;48(12):2333-9.
1999: Bovin L F; Bendtzen K
[Apoptosis--programmed cell death]
Ugeskrift for laeger 1999;161(42):5778-82.
1999: Zaccone P; Phillips J; Conget I; Gomis R; Haskins K; Minty A; Bendtzen K; Cooke A; Nicoletti F
Interleukin-13 prevents autoimmune diabetes in NOD mice.
Diabetes 1999;48(8):1522-8.
1999: Bovin L F; Fredman P; Månsson J E; Buschard K; Bendtzen K
In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide.
FEBS letters 1999;455(3):339-43.
1999: Ostergaard K; Andersen C B; Petersen J; Bendtzen K; Salter D M
Validity of histopathological grading of articular cartilage from osteoarthritic knee joints.
Annals of the rheumatic diseases 1999;58(4):208-13.
1999: Strandell E; Kaas A; Hartoft-Nielsen M L; Bock T; Buschard K; Bendtzen K
Cytokine production in NOD mice on prophylactic insulin therapy.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1999;107(4):413-9.
1999: Birkeland S A; Bendtzen K; Møller B; Hamilton-Dutoit S; Andersen H K
Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.
Transplantation 1999;67(6):876-81.
1999: Andersen L S; Petersen J; Svenson M; Bendtzen K
Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE.
Autoimmunity 1999;30(4):235-42.
1998: Calogero A E; Nicoletti F; Palumbo M A; Burrello N; Di Mauro M; Lunetta M; Bendtzen K; Cianci A
Macrophage-derived cytokines in the follicular fluids of women with infertility due to immunological causes. Elevated levels of interleukin 6 and low levels of granulocyte-macrophage colony-stimulating factor.
Cytokine 1998;10(10):814-8.
1998: Nicoletti F; Nicoletti A; Giuffrida S; Di Marco R; Meroni P; Bendtzen K; Lunetta M
Sodium fusidate in Gillain-Barré syndrome: a case report.
Journal of neurology, neurosurgery, and psychiatry 1998;65(2):266-8.
1998: Ostergaard K; Salter D M; Petersen J; Bendtzen K; Hvolris J; Andersen C B
Expression of alpha and beta subunits of the integrin superfamily in articular cartilage from macroscopically normal and osteoarthritic human femoral heads.
Annals of the rheumatic diseases 1998;57(5):303-8.
1998: Müller K; Herner E B; Stagg A; Bendtzen K; Woo P
Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis.
British journal of rheumatology 1998;37(5):562-9.
1998: Bendtzen K; Hansen M B; Ross C; Svenson M
High-avidity autoantibodies to cytokines.
Immunology today 1998;19(5):209-11.
1998: Bendtzen K
Autoantibodies to cytokines.
European journal of clinical investigation 1998;28(4):300-1.
1998: Svenson M; Hansen M B; Ross C; Diamant M; Rieneck K; Nielsen H; Bendtzen K
Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.
Blood 1998;91(6):2054-61.
1998: Henriques C U; Rice G E; Wong M H; Bendtzen K
Immunolocalisation of interleukin-4 and interleukin-4 receptor in placenta and fetal membranes in association with pre-term labour and pre-eclampsia.
Gynecologic and obstetric investigation 1998;46(3):172-7.
1997: Nicoletti F; Beltrami B; Raschi E; Di Marco R; Magro G; Grasso S; Bendtzen K; Fiorelli G; Meroni P L
Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate.
Clinical and experimental immunology 1997;110(3):479-84.
1997: Ostergaard K; Salter D M; Andersen C B; Petersen J; Bendtzen K
CD44 expression is up-regulated in the deep zone of osteoarthritic cartilage from human femoral heads.
Histopathology 1997;31(5):451-9.
1997: Ostergaard K; Petersen J; Andersen C B; Bendtzen K; Salter D M
Histologic/histochemical grading system for osteoarthritic articular cartilage: reproducibility and validity.
Arthritis and rheumatism 1997;40(10):1766-71.
1997: Ciapponi L; Maione D; Scoumanne A; Costa P; Hansen M B; Svenson M; Bendtzen K; Alonzi T; Paonessa G; Cortese R; Ciliberto G; Savino R
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist.
Nature biotechnology 1997;15(10):997-1001.
1997: Ross C; Svenson M; Nielsen H; Lundsgaard C; Hansen M B; Bendtzen K
Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy.
Blood 1997;90(6):2376-80.
1997: Pedersen G; Dalseg A M; Brynskov J; Bendtzen K
[The role of cell adhesion molecules in inflammatory bowel disease and colorectal cancer]
Ugeskrift for laeger 1997;159(34):5077-84.
1997: Ullum H; Cozzi Lepri A; Bendtzen K; Victor J; Gøtzsche P C; Phillips A N; Skinhøj P; Klarlund Pedersen B
Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individuals.
AIDS research and human retroviruses 1997;13(12):1039-46.
1997: Müller K; Zak M; Nielsen S; Pedersen F K; de Nully P; Bendtzen K
Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis.
Clinical and experimental rheumatology 1997;15(4):439-44.
1997: Diamant M; Rieneck K; Mechti N; Zhang X G; Svenson M; Bendtzen K; Klein B
Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130.
FEBS letters 1997;412(2):379-84.
1997: Nicoletti F; Mancuso G; Cusumano V; Di Marco R; Zaccone P; Bendtzen K; Teti G
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13.
European journal of immunology 1997;27(6):1580-3.
1997: Ullum H; Victor J; Katzenstein T L; Gerstoft J; Gøtzsche P C; Bendtzen K; Skinhøj P; Pedersen B K
Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjects.
The Journal of infectious diseases 1997;175(6):1507-10.
1997: Jakobsen P H; Koch C; Bendtzen K
Inhibition of LPS and Plasmodium falciparum induced cytokine secretion by pentoxifylline and two analogues.
Scandinavian journal of immunology 1997;45(5):546-50.
1997: Bendtzen K; Feldt-Rasmussen U F
[Chemokines and HIV infection]
Ugeskrift for laeger 1997;159(13):1956-7.
1997: Abrahamsen B; Bendtzen K; Beck-Nielsen H
Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.
Bone 1997;20(3):251-8.
1997: Bygbjerg I C; Hansen M B; Rønn A M; Bendtzen K; Jakobsen P H
Decreased plasma levels of factor II + VII + X correlate with increased levels of soluble cytokine receptors in patients with malaria and meningococcal infections.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1997;105(2):150-6.
1997: Rieneck K; Renneberg J; Diamant M; Gutschik E; Bendtzen K
Molecular cloning and expression of a novel Staphylococcus aureus antigen.
Biochimica et biophysica acta 1997;1350(2):128-32.
1997: Asmussen K; Andersen V; Bendixen G; Bendtzen K; Prause J U; Thorn J; Wiik A; Oxholm P
Quantitative assessment of clinical disease status in primary Sjögren's syndrome. A cross-sectional study using a new classification model.
Scandinavian journal of rheumatology 1997;26(3):197-205.
1996: Buschard K; Diamant M; Bovin L E; Månsson J E; Fredman P; Bendtzen K
Sulphatide and its precursor galactosylceramide influence the production of cytokines in human mononuclear cells.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1996;104(12):938-44.
1996: Homann C; Hansen M B; Graudal N; Hasselqvist P; Svenson M; Bendtzen K; Thomsen A C; Garred P
Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis.
Scandinavian journal of immunology 1996;44(6):623-9.
1996: Ullum H; Diamant M; Victor J; Gøtzsche P C; Bendtzen K; Skinhøj P; Pedersen B K
Increased circulating levels of interleukin-6 in HIV-seropositive subjects.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13(1):93-4.
1996: Müller K; Zak M; Nielsen S; Pedersen F K; de Nully P; Bendtzen K
In vitro cytokine production and phenotype expression by blood mononuclear cells from umbilical cords, children and adults.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 1996;7(3):117-24.
1996: Jakobsen P H; McKay V; N'Jie R; Olaleye B O; D'Alessandro U; Bendtzen K; Schousboe I; Greenwood B M
Soluble products of inflammatory reactions are not induced in children with asymptomatic Plasmodium falciparum infections.
Clinical and experimental immunology 1996;105(1):69-73.
1996: Diamant M; Hansen M B; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
Leukemia research 1996;20(4):291-301.
1996: Nicoletti F; Meroni P L; Bendtzen K
Fusidic acid and insulin-dependent diabetes mellitus.
Autoimmunity 1996;24(3):187-97.
1996: Müller K; Hansen M B; Zak M; Nielsen S; Pedersen F K; de Nully P; Bendtzen K
Autoantibodies to IL-1 alpha in sera from umbilical cords, children, and adults, and from patients with juvenile chronic arthritis.
Scandinavian journal of rheumatology 1996;25(3):164-7.
1995: Bendtzen K
[Molecular biology and inflammation]
Ugeskrift for laeger 1995;157(35):4799-802.
1995: Nicoletti F; Zaccone P; Di Marco R; Magro G; Grasso S; Morrone S; Santoni A; Tempera G; Meroni P L; Bendtzen K
Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.
Immunology 1995;85(4):645-50.
1995: Hansen M B; Svenson M; Diamant M; Abell K; Bendtzen K
Interleukin-6 autoantibodies: possible biological and clinical significance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(7):1113-5.
1995: Ross C; Svenson M; Hansen M B; Vejlsgaard G L; Bendtzen K
High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
The Journal of clinical investigation 1995;95(5):1974-8.
1995: Bendtzen K; Hansen M B; Ross C; Poulsen L K; Svenson M
Cytokines and autoantibodies to cytokines.
Stem cells (Dayton, Ohio) 1995;13(3):206-22.
1995: Bendixen G; Bendtzen K
[Molecular biology and rheumatology]
Ugeskrift for laeger 1995;157(17):2421-3.
1995: Josefsen K; Nielsen H; Hansen W A; Kristensen J K; Bilde T; Bendtzen K; Buschard K
Tissue culture supernatants from human islets of Langerhans activate the oxidative burst response of human monocytes in vitro.
Life sciences 1995;56(16):1333-42.
1995: Hansen M B; Svenson M; Abell K; Yasukawa K; Diamant M; Bendtzen K
Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors.
European journal of immunology 1995;25(2):348-54.
1995: Andersen L S; Petersen J; Svenson M; Bendtzen K
IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: an in vitro phenomenon depending upon plastic adherence.
Autoimmunity 1995;22(2):127-33.
1995: Rodgaard A; Thomsen B S; Bendixen G; Bendtzen K
Increased expression of complement receptor type 1 (CR1, CD35) on human peripheral blood T lymphocytes after polyclonal activation in vitro.
Immunologic research 1995;14(1):69-76.
1995: Hansen M B; Andersen V; Rohde K; Florescu A; Ross C; Svenson M; Bendtzen K
Cytokine autoantibodies in rheumatoid arthritis.
Scandinavian journal of rheumatology 1995;24(4):197-203.
1994: Kemp M; Hey A S; Bendtzen K; Kharazmi A; Theander T G
Th1-like human T-cell clones recognizing Leishmania gp63 inhibit Leishmania major in human macrophages.
Scandinavian journal of immunology 1994;40(6):629-35.
1994: Bendtzen K
Cytokines and natural regulators of cytokines.
Immunology letters 1994;43(1-2):111-23.
1994: Rasmussen A K; Nielsen H; Andersen V; Barington T; Bendtzen K; Hansen M B; Nielsen L; Pedersen B K; Wiik A
[Chronic fatigue syndrome--a controlled cross-sectional study]
Ugeskrift for laeger 1994;156(46):6836-40.
1994: Rasmussen A K; Kayser L; Feldt-Rasmussen U; Bendtzen K
Influence of tumour necrosis factor-alpha, tumour necrosis factor-beta and interferon-gamma, separately and added together with interleukin-1 beta, on the function of cultured human thyroid cells.
The Journal of endocrinology 1994;143(2):359-65.
1994: Jakobsen P H; McKay V; Morris-Jones S D; McGuire W; van Hensbroek M B; Meisner S; Bendtzen K; Schousboe I; Bygbjerg I C; Greenwood B M
Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria.
Infection and immunity 1994;62(10):4374-9.
1994: Horn T; Bendtzen K; Hageman I; Buschard K
Morphological effects of sodium fusidate (fusidin) on pancreatic islet cells: an electron microscopic study.
Pharmacology & toxicology 1994;75(3-4):228-30.
1994: Diamant M; Hansen M B; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors.
Journal of immunological methods 1994;173(2):229-35.
1994: Rasmussen A K; Nielsen H; Andersen V; Barington T; Bendtzen K; Hansen M B; Nielsen L; Pedersen B K; Wiik A
Chronic fatigue syndrome--a controlled cross sectional study.
The Journal of rheumatology 1994;21(8):1527-31.
1994: Jakobsen P H; Morris-Jones S; Theander T G; Hviid L; Hansen M B; Bendtzen K; Ridley R G; Greenwood B M
Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria.
Clinical and experimental immunology 1994;96(1):98-103.
1994: Hansen M B; Svenson M; Abell K; Varming K; Nielsen H P; Bertelsen A; Bendtzen K
Sex- and age-dependency of IgG auto-antibodies against IL-1 alpha in healthy humans.
European journal of clinical investigation 1994;24(3):212-8.
1994: Nicoletti F; Di Marco R; Morrone S; Zaccone P; Lembo D; Grasso S; Santoni A; Meroni P L; Bendtzen K
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma.
Immunology 1994;81(2):317-21.
1994: Nielsen M; Odum N; Bendtzen K; Ryder L P; Jakobsen B K; Svejgaard A
MHC class II molecules regulate growth in human T cells.
Experimental and clinical immunogenetics 1994;11(1):23-32.
1993: Svenson M; Hansen M B; Bendtzen K
Binding of cytokines to pharmaceutically prepared human immunoglobulin.
The Journal of clinical investigation 1993;92(5):2533-9.
1993: Kemp M; Kurtzhals J A; Christensen C B; Kharazmi A; Jardim A; Bendtzen K; Gachihi G S; Olafson R W; Theander T G
Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein.
Immunology letters 1993;38(2):137-44.
1993: Andersen A; Pedersen H; Bendtzen K; Röpke C
Effects of growth factors on cytokine production in serum-free cultures of human thymic epithelial cells.
Scandinavian journal of immunology 1993;38(3):233-8.
1993: Svenson M; Hansen M B; Heegaard P; Abell K; Bendtzen K
Specific binding of interleukin 1 (IL-1) beta and IL-1 receptor antagonist (IL-1ra) to human serum. High-affinity binding of IL-1ra to soluble IL-1 receptor type I.
Cytokine 1993;5(5):427-35.
1993: Rieneck K; Diamant M; Haahr P M; Schönharting M; Bendtzen K
In vitro immunomodulatory effects of pentoxifylline.
Immunology letters 1993;37(2-3):131-8.
1993: Kronborg G; Hansen M B; Svenson M; Fomsgaard A; Høiby N; Bendtzen K
Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.
Pediatric pulmonology 1993;15(5):292-7.
1993: Kemp M; Kurtzhals J A; Bendtzen K; Poulsen L K; Hansen M B; Koech D K; Kharazmi A; Theander T G
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
Infection and immunity 1993;61(3):1069-73.
1993: Müller K; Odum N; Bendtzen K
1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro.
Immunology letters 1993;35(2):177-82.
1993: Hansen M B; Svenson M; Diamant M; Bendtzen K
High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro.
Cytokine 1993;5(1):72-80.
1992: Müller K; Haahr P M; Diamant M; Rieneck K; Kharazmi A; Bendtzen K
1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level.
Cytokine 1992;4(6):506-12.
1992: Müller K; Rieneck K; Hansen M B; Bendtzen K
1,25-Dihydroxyvitamin D3-mediated suppression of T lymphocyte functions and failure of T cell-activating cytokines to restore proliferation.
Immunology letters 1992;34(1):37-44.
1992: Langholz E; Brynskov J; Bendtzen K; Vilien M; Binder V
Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin.
Alimentary pharmacology & therapeutics 1992;6(4):495-502.
1992: Kjaer T W; Rygaard J; Bendtzen K; Josefsen K; Bock T; Buschard K
Interleukins increase surface ganglioside expression of pancreatic islet cells in vitro.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1992;100(6):509-14.
1992: Hansen M B; Svenson M; Bendtzen K
Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-alpha in normal human sera.
Clinical and experimental immunology 1992;88(3):559-62.
1992: Christensen L D; Andersen V; Nygaard P; Bendtzen K
Effects of immunomodulators on ecto-5'-nucleotidase activity on blood mononuclear cells in vitro.
Scandinavian journal of immunology 1992;35(4):407-13.
1992: Bendtzen K; Diamant M; Horn T; Pedersen C; Buschard K
Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats.
The Journal of endocrinology 1992;132(3):345-52.
1992: Svenson M; Hansen M B; Kayser L; Rasmussen A K; Reimert C M; Bendtzen K
Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1.
Cytokine 1992;4(2):125-33.
1992: Müller K; Pedersen F K; Wiik A; Bendtzen K
Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.
Rheumatology international 1992;12(3):89-92.
1992: Buschard K; Pedersen C; Hansen S V; Hageman I; Aaen K; Bendtzen K
Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats.
Autoimmunity 1992;14(2):101-4.
1992: Müller K; Bendtzen K
Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells.
Autoimmunity 1992;14(1):37-43.
1992: Kristensen K S; Bendtzen K; Skov P S; Pedersen M; Permin H; Norn S
Modulation of IgE-mediated basophil histamine release by various cytokines.
Pneumonologia i alergologia polska : organ Polskiego Towarzystwa Ftyzjopneumonologicznego, Polskiego Towarzystwa Alergologicznego, i Instytutu Gruzlicy i Chorób Pluc 1992;60 Suppl 2():70-3.
1991: Hansen M B; Svenson M; Bendtzen K
Human anti-interleukin 1 alpha antibodies.
Immunology letters 1991;30(1):133-9.
1991: Hansen M B; Svenson M; Diamant M; Bendtzen K
Anti-interleukin-6 antibodies in normal human serum.
Scandinavian journal of immunology 1991;33(6):777-81.
1991: Müller K; Diamant M; Bendtzen K
Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3.
Immunology letters 1991;28(2):115-20.
1991: Haahr P M; Pedersen B K; Fomsgaard A; Tvede N; Diamant M; Klarlund K; Halkjaer-Kristensen J; Bendtzen K
Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-alpha, interleukin 2 and interferon-gamma.
International journal of sports medicine 1991;12(2):223-7.
1991: Svenson M; Kayser L; Hansen M B; Rasmussen A K; Bendtzen K
Interleukin-1 receptors on human thyroid cells and on the rat thyroid cell line FRTL-5.
Cytokine 1991;3(2):125-30.
1991: Pedersen M; Permin H; Bindslev-Jensen C; Bendtzen K; Norn S
Cytokine-induced histamine release from basophils of AIDS patients. Interaction between cytokines and specific IgE antibodies.
Allergy 1991;46(2):129-34.
1990: Svenson M; Bagge Hansen M; Bendtzen K
Distribution and characterization of autoantibodies to interleukin 1 alpha in normal human sera.
Scandinavian journal of immunology 1990;32(6):695-701.
1990: Bendtzen K; Diamant M; Faber V
Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A.
Cytokine 1990;2(6):423-9.
1990: Müller K; Oxholm P; Sørensen O H; Thymann M; Høier-Madsen M; Bendtzen K
Abnormal vitamin D3 metabolism in patients with primary Sjögren's syndrome.
Annals of the rheumatic diseases 1990;49(9):682-4.
1990: Hviid L; Theander T G; Jakobsen P H; Abu-Zeid Y A; Abdulhadi N H; Saeed B O; Jepsen S; Bayoumi R A; Bendtzen K; Jensen J B
Cell-mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(7):594-604.
1990: Bendtzen K; Svenson M; Jønsson V; Hippe E
Autoantibodies to cytokines--friends or foes?
Immunology today 1990;11(5):167-9.
1990: Pedersen M; Permin H; Bendtzen K; Norn S
Cytokine-induced release of histamine from basophil leukocytes from AIDS patients.
Agents and actions 1990;30(1-2):294-6.
1990: Buschard K; Aaen K; Horn T; Van Damme J; Bendtzen K
Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans.
Autoimmunity 1990;5(3):185-94.
1989: Svenson M; Bendtzen K
Human urine deoxyribonuclease increases endogenous thymidine in the mouse thymocyte interleukin 1 assay: an artificial interleukin-1 inhibitor.
Cytokine 1989;1(1):52-5.
1989: Fomsgaard A; Svenson M; Bendtzen K
Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections.
Scandinavian journal of immunology 1989;30(2):219-23.
1989: Svenson M; Poulsen L K; Fomsgaard A; Bendtzen K
IgG autoantibodies against interleukin 1 alpha in sera of normal individuals.
Scandinavian journal of immunology 1989;29(4):489-92.
1989: Bendtzen K
Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases.
Autoimmunity 1989;2(2):177-89.
1988: Bendtzen K; Morling N; Fomsgaard A; Svenson M; Jakobsen B; Odum N; Svejgaard A
Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide.
Scandinavian journal of immunology 1988;28(5):599-606.
1988: Bendtzen K
Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity.
Immunology letters 1988;19(3):183-91.
1988: Bouchelouche P N; Reimert C; Bendtzen K
Effects of natural and recombinant interleukin-1 alpha and -beta on cytosolic free calcium in human and murine fibroblasts.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(10):691-6.
1988: Kharazmi A; Nielsen H; Bendtzen K
Modulation of human neutrophil and monocyte chemotaxis and superoxide responses by recombinant TNF-alpha and GM-CSF.
Immunobiology 1988;177(4-5):363-70.
1988: Theander T G; Kharazmi A; Pedersen B K; Christensen L D; Tvede N; Poulsen L K; Odum N; Svenson M; Bendtzen K
Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.
Infection and immunity 1988;56(7):1673-7.
1988: Pedersen B K; Tvede N; Hansen F R; Andersen V; Bendix T; Bendixen G; Bendtzen K; Galbo H; Haahr P M; Klarlund K
Modulation of natural killer cell activity in peripheral blood by physical exercise.
Scandinavian journal of immunology 1988;27(6):673-8.
1988: Tvede N; Christensen L D; Odum N; Wiik A; Bendtzen K
Interleukin 1-induced down-regulation of antibody binding to CD4 molecules on human lymphocytes.
Scandinavian journal of immunology 1988;27(6):679-84.
1988: Svenson M; Bendtzen K
Inhibitor of interleukin 1 in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line.
Scandinavian journal of immunology 1988;27(5):593-9.
1988: Muller K; Svenson M; Bendtzen K
1 alpha,25-Dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro.
Immunology letters 1988;17(4):361-5.
1988: Kharazmi A; Nielsen H; Bendtzen K
Recombinant interleukin 1 alpha and beta prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils.
Immunobiology 1988;177(1):32-9.
1988: Fomsgaard A; Worsaae H; Bendtzen K
Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay.
Scandinavian journal of immunology 1988;27(2):143-7.
1984: Oxholm P; Winther K; Bendtzen K; Bendixen G
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study.
Allergy 1984;39(8):618-21.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Klaus Bendtzen

Research Profile (preview)

Chemicals & Drugs

Anatomy

Procedures

Living Beings

Physiology

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Klaus Bendtzen (preview)

All Publications